KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gevo (GEVO) Research & Development (2016 - 2025)

Gevo has reported Research & Development over the past 16 years, most recently at $1.3 million for Q4 2025.

  • Quarterly results put Research & Development at $1.3 million for Q4 2025, up 1.33% from a year ago — trailing twelve months through Dec 2025 was $4.6 million (down 18.4% YoY), and the annual figure for FY2025 was $4.6 million, down 18.4%.
  • Research & Development for Q4 2025 was $1.3 million at Gevo, up from $1.3 million in the prior quarter.
  • Over the last five years, Research & Development for GEVO hit a ceiling of $2.7 million in Q4 2022 and a floor of $934000.0 in Q2 2025.
  • Median Research & Development over the past 5 years was $1.4 million (2021), compared with a mean of $1.5 million.
  • Biggest five-year swings in Research & Development: soared 137.59% in 2021 and later tumbled 43.08% in 2025.
  • Gevo's Research & Development stood at $2.6 million in 2021, then grew by 5.33% to $2.7 million in 2022, then dropped by 29.04% to $1.9 million in 2023, then plummeted by 33.68% to $1.3 million in 2024, then increased by 1.33% to $1.3 million in 2025.
  • The last three reported values for Research & Development were $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $934000.0 (Q2 2025) per Business Quant data.